If you need more lookups,
subscriptions start at $34 USD/month.
James Singleton Location
Zürich, ZH, CH
James Singleton Work
Chief Legal Officer, General Counsel and Board Secretary @ (October 2021 - Present)
Co-Chair and Speaker – 6th Annual In-House Impact: Biopharma Summit @ (August 2025 - August 2025)
General Counsel - US @ (November 2016 - October 2021)
General Counsel @ (November 2016 - October 2021)
Member Board of Directors @ (January 2018 - September 2021)
Member Board of Directors @ York River Holdings LLC (November 2018 - August 2021)
Member Board of Directors @ (January 2018 - January 2020)
Head of Legal - Merck Biopharma Global Business Development, M Ventures and Merck Biosimilars @ (January 2012 - November 2016)
Associate General Counsel @ (January 2007 - December 2011)
Associate General Counsel @ Serono International (acquired by Merck KGaA in 2007) (October 2004 - January 2007)
James Singleton Education
New York University School of Law
Juris Doctor (Law)
University at Albany
BA (Political Science)
James Singleton Skills
Licensing
Pharmaceutical Industry
Intellectual Property
Biotechnology
Patents
Corporate Law
Life Sciences
Venture Capital
Biopharmaceuticals
Commercialization
International Negotiations
Change Management
Cross-functional Team Leadership
International
International M&A
Cross Functional Team Leadership
Cross Functional Team
James Singleton Summary
James Singleton, based in Zürich, ZH, CH, is currently a Chief Legal Officer, General Counsel and Board Secretary at Numab Therapeutics AG. James Singleton brings experience from previous roles at Hanson Wade Group, B-FLEXION, Gurnet Point Capital and Auregen BioTherapeutics. James Singleton holds a Juris Doctor in Law @ New York University School of Law. With a robust skill set that includes Licensing, Pharmaceutical Industry, Intellectual Property, Biotechnology, Patents and more. James Singleton has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different James Singleton?
Find contact details for 700 million professionals.